Please join Independent Investment Bankers in congratulating Dan Ross with Biopharma Capital on assisting with a strategic partnership for Covenlo Therapeutics, a biotechnology company based in Cleveland, OH. This collaboration will accelerate discovery and development of novel remyelinating medicines for patients with neurological disorders such as multiple sclerosis (MS).
If you would like to learn more about this deal, discuss potentially mutually beneficial opportunities, or are a Company seeking assistance with achieving your financials goals, feel free to contact Biopharma Capital.
We’d love to hear from you. Reach out to us at (512) 266-3000